ischemic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

is·che·mi·a

 (ĭ-skē′mē-ə)
n.
A decrease in the blood supply to a bodily organ, tissue, or part caused by constriction or obstruction of the blood vessels.

[New Latin ischaemia, from Greek iskhaimos, a stopping of the blood : iskhein, to keep back; see segh- in Indo-European roots + haima, blood.]

i·sche′mic adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.ischemic - relating to or affected by ischemia
Translations
ischemický

is·che·mic

a. isquémico-a, que padece de isquemia o rel. a la misma.

ischemic

adj isquémico
References in periodicals archive ?
7, 2019 (HealthDay News) -- Antidepressants strongly inhibiting serotonin reuptake may be associated with a small reduction in the rate of ischemic stroke compared with weak reuptake inhibitors, according to a study published online Aug.
M2 EQUITYBITES-July 19, 2019-Pharmazz Inc begins Phase III trial of PMZ-1620 in cerebral ischemic stroke patients
M2 PHARMA-July 19, 2019-Pharmazz Inc begins Phase III trial of PMZ-1620 in cerebral ischemic stroke patients
Global Banking News-July 19, 2019-Pharmazz Inc begins Phase III trial of PMZ-1620 in cerebral ischemic stroke patients
PHILADELPHIA -- Older adults who report more depressive symptoms may be at greater risk of ischemic stroke, according to preliminary data from a prospective study presented at the annual meeting of the American Academy of Neurology.
Keywords: Frequency, General health questionnaire, Ischemic heart disease, Psychological stress, Physical inactivity, World health organization disability assessment schedule.
Objectives: It is known that the neutrophil/lymphocyte ratio (NLR) is associated with adverse outcomes in ischemic stroke patients.
Currently, tPA - a thrombolytic used to break down blood clots in patients suffering from ischemic stroke - is the only FDA-approved therapeutic stroke treatment.
MONTREAL -- The optimal length for dual-antiplatelet therapy in patients who have just had a mild stroke or transient ischemic attack is 21 days, a duration of combined treatment that maximized protection against major ischemic events while minimizing the extra risk for a major hemorrhage, according to a prespecified analysis of data from the POINT trial.
They used previously validated ICD-9-CM diagnosis codes to ascertain the exposure variable of acute MI and the outcome of ischemic stroke but excluded strokes that occurred during an acute MI hospitalization.
Objective: To find out the frequency of atrial fibrillation in patients with acute ischemic stroke presenting to a tertiary care hospital.